Quantcast
Connect with us

Treating COVID-19 with Trump-hyped drug creates ‘significantly higher risk of death’: study

Published

on

President Donald Trump for months has been touting the benefits of taking hydroxychloroquine as a treatment for COVID-19.

However, a massive new study published in the medical journal Lancet has found that treating COVID-19 patients with hydroxychloroquine results in a “significantly higher risk of death.”

As the Washington Post reports, the study is based on examining health outcomes from 96,000 COVID-infected patients across the world.

ADVERTISEMENT

And the study’s findings didn’t show just minor differences between patients who took hydroxychloroquine and those who didn’t.

“For those given hydroxychloroquine, there was a 34 percent increase in risk of mortality and a 137 percent increased risk of a serious heart arrhythmias,” the Post writes. “For those receiving hydroxychloroquine and an antibiotic — the cocktail endorsed by Trump — there was a 45 percent increased risk of death and a 411 percent increased risk of serious heart arrhythmias.”

Although it is not a controlled study, its sample size is so large that many scientists say it should nonetheless be taken seriously.

“It’s one thing not to have benefit, but this shows distinct harm,” Eric Topol, a cardiologist and director of the Scripps Research Translational Institute, tells the Post. “If there was ever was hope for this drug, this is the death of it.”

And David Maron, director of preventive cardiology at the Stanford University School of Medicine, tells the Post that the study provides “absolutely no reason for optimism that these drugs might be useful in the prevention or treatment of COVID-19.”

ADVERTISEMENT

Read the entire study at this link.


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

Breaking Banner

New Zealand may postpone general election after 4 test positive for COVID-19: PM Jacinda Ardern

Published

on

New Zealand locked down nursing homes nationwide Wednesday after a 102-day streak without the coronavirus ended, as Prime Minister Jacinda Ardern said the outbreak could force her to postpone next month's general election.

Ardern said authorities were scrambling to trace anyone who had been in contact with four Auckland residents who tested positive Tuesday, ending the dream run in which the virus had been contained at New Zealand's borders.

A three-day stay-at-home order for Auckland, New Zealand's biggest city with a population of 1.5 million, was announced on Tuesday night and went into force at lunchtime on Wednesday.

Continue Reading

2020 Election

Android phones to get ‘ShakeAlert’ earthquake warnings — and phones may double as tremor detectors

Published

on

Android phones will receive warnings triggered by a "ShakeAlert" earthquake early-warning system implemented on the West Coast by the US Geological Survey and partners.

ShakeAlert uses signals from hundreds of seismometers across the state to trigger warning messages that "an earthquake has begun and shaking is imminent," according to the system's website.

"We saw an opportunity to use Android to provide people with timely, helpful earthquake information when they search, as well as a few seconds warning to get themselves and their loved ones to safety if needed," principal software engineer Marc Stogaitis said in a blog post.

Continue Reading
 

2020 Election

‘Don’t talk about racism, racist’: Trump scorched after claiming Biden-Harris campaign has a ‘racism problem’

Published

on

President Donald Trump continued to lash out at Kamala Harris after the California Democrat was chosen to join the 2020 Democratic Party ticket as presumptive nominee Joe Biden's running mate.

At a news conference following the selection, Trump complained about Harris being "nasty."

After 10 p.m. on Monday, Trump tweeted out an attack ad claiming "Joe Biden has a racism problem."

Here's some of what people were saying about Trump's line of attack:

Continue Reading
 
 
You need honest news coverage. Help us deliver it. Join Raw Story Investigates for $1. Go ad-free.
close-image